The Indian Journal of Pediatrics

, Volume 79, Issue 4, pp 478–482 | Cite as

Efficacy and Safety of Saccharomyces boulardii in Acute Childhood Diarrhea: A Double Blind Randomised Controlled Trial

  • Musheer Riaz
  • Seema Alam
  • Abida Malik
  • S. Manazir Ali
Original Article



To see the efficacy and safety of 250 mg of Saccharomyces boulardii twice daily for 5 d in acute childhood diarrhea.


Children aged between 3 mo and 59 mo with acute onset diarrhea (of less than 48 h) admitted in DTTU (diarrhea treatment and training unit) were included and those with clinical evidence of severe malnutrition, systemic infection, encephalopathy and/or convulsion, electrolyte imbalance, invasive diarrhea or previous use of any probiotics were excluded from the study. Those included randomly were given either a placebo or Saccharomyces boullardi (SB) in identical packets mixed with puffed rice powder.


Mean post intervention duration of diarrhea was significantly (95% CI = −28.13 to −5.43) shorter in SB group (52.08 ± 24.57 h) as compared to placebo group (64.04 ± 30.43 h). The time of appearance of first semi formed stool in SB group (39.48 ± 23.09 h) was significantly (95% CI −25.4 to −3.87) shorter than the placebo group (54.13 ± 28.21 h). No statistically significant difference was found in rest of the parameters.


There is initial evidence available that SB may have a therapeutic role in the management of acute childhood diarrhea.


Acute diarrhea Probiotics Saccharomyces boularrdii Therapeutic role 


Conflict of Interest


Role of Funding Source



  1. 1.
    Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ. 2003;81:197–204.PubMedGoogle Scholar
  2. 2.
    O'Ryan M, Prado V, Pickering LK. A millennium update on pediatric diarrheal illness in the developing world. Semin Pediatr Infect Dis. 2005;16:125–36.PubMedCrossRefGoogle Scholar
  3. 3.
    Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ. Efficacy of probiotic use in acute diarrhoea in children: a meta-analysis. Dig Dis Sci. 2002;11:2625–3634.CrossRefGoogle Scholar
  4. 4.
    Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhoea in children:a meta-analysis. Pediatrics. 2002;109:678–84.PubMedCrossRefGoogle Scholar
  5. 5.
    McFarland LV, Elmer GW, McFarland M. Meta-analysis of Probiotics for the prevention and treatment of Acute Pediatric Diarrhea. Int J Probiotics Prebiotics. 2006;1:63–76.Google Scholar
  6. 6.
    Cetina-Sauri G, Sierra Basto G. Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhea. Annales De Pediatrie. 1994;41:397–400.Google Scholar
  7. 7.
    Hafeez A, Tariq P, Ali S, Kundi ZU, Khan A, Hassan M. The efficacy of saccharomyces boulardii in the treatment of acute watery diarrhea of children: A multicentre randomized controlled trial. J Coll Physicians Surg Pak. 2002;12:432–4.Google Scholar
  8. 8.
    Kurugol Z, Koturoglu G. Effect of Saccharomyces boulardii in children with acute diarrhoea. Acta Pediatr. 2005;94:44–7.CrossRefGoogle Scholar
  9. 9.
    Billo AG, Memon MA, Khaskheli SA, et al. Role of probiotic (Saccharomics boulardii) in management and prevention of diarrhea. World J Gastroenterol. 2006;12:4557–60.Google Scholar
  10. 10.
    Villarruel G, Rubio DM, Lopez F, et al. Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study. Acta Pediatr. 2007;96:538–41.CrossRefGoogle Scholar
  11. 11.
    Htwe K, Yee KS, Tin M, Vandenplas Y. Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children: A randomized controlled study. Am J Trop Med Hyg. 2008;78:214–6.PubMedGoogle Scholar
  12. 12.
    Eren M, Dinleyici EC, Vandenplas Y. Clinical efficacy comparison of Saccharomyces boulardii and yogurt fluid in acute non-bloody diarrhea in children: a randomized, controlled, open label study. Am J Trop Med Hyg. 2010;82:488–91.PubMedCrossRefGoogle Scholar
  13. 13.
    Le Luyer B, Makhoul G, Duhamel JF. A multicentric study of a lactose free formula supplemented with Saccharomyces boulardii in children with acute diarrhea. Arch Pediatr. 2010;17:459–65.PubMedCrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2011

Authors and Affiliations

  • Musheer Riaz
    • 1
  • Seema Alam
    • 2
  • Abida Malik
    • 3
  • S. Manazir Ali
    • 1
  1. 1.Department of PediatricsJawaharlal Nehru Medical College, AMUAligarhIndia
  2. 2.Department of Pediatric HepatologyInstitute of Liver and Biliary SciencesNew DelhiIndia
  3. 3.Department of MicrobiologyJawaharlal Nehru Medical College, AMUAligarhIndia

Personalised recommendations